Ysios Capital logo

Ysios Capital

Europe, Pais Vasco, Spain, San Sebastian

Description

Ysios Capital is a leading life sciences investor financing highly innovative companies worldwide

Investor Profile

Ysios Capital has made 72 investments, with 3 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (28%)
  • Series B (28%)
  • Series C (18%)
  • Series Unknown (11%)
  • Series D (7%)
  • Series E (3%)
  • Series F (3%)
  • Series G (1%)
  • Post Ipo Equity (1%)

Country Focus

  • Spain (33%)
  • United States (18%)
  • The Netherlands (17%)
  • Switzerland (10%)
  • Denmark (10%)
  • France (7%)
  • Sweden (3%)
  • United Kingdom (1%)
  • Belgium (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Medical Device
  • Health Diagnostics
  • Life Science
  • Biopharma
  • Hospital
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ysios Capital frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
Criteria Venture Tech
Europe, Catalonia, Spain, Barcelona
Co-Investments: 12
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 10
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 9
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 8
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 13
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 8
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 11
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 8
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 14

Which angels does Ysios Capital often collaborate with?

HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1

What are some of recent deals done by Ysios Capital?

ReproNovo

Lausanne, Vaud, Switzerland

ReproNovo specializes in reproductive health and women's health.

BiotechnologyFertilityHealth CareLife Science
Series AMay 21, 2025
Amount Raised: $65,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
ADCendo

Copenhagen, Hovedstaden, Denmark

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

BiotechnologyHealth Care
Series BNov 25, 2024
Amount Raised: $135,000,000
ADCendo

Copenhagen, Hovedstaden, Denmark

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

BiotechnologyHealth Care
Series AMay 29, 2024
Amount Raised: $17,281,921
Memo Therapeutics

Schlieren, Zurich, Switzerland

Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.

BiotechnologyCollaboration
Series CMay 7, 2024
Amount Raised: $22,015,012
Engrail Therapeutics

San Diego, California, United States

Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.

Health CareLife ScienceMedicalPharmaceutical
Series BMar 19, 2024
Amount Raised: $157,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series EFeb 8, 2024
Amount Raised: $120,000,000
Kynexis

Naarden, Noord-Holland, The Netherlands

Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment associated with schizophrenia (CIAS).

BiotechnologyHealth CareMedicalTherapeutics
Series ANov 7, 2023
Amount Raised: $60,970,914
Xeltis

Eindhoven, Noord-Brabant, The Netherlands

Xeltis is a clinical-stage medtech company with the world’s most advanced polymer-based platform of restorative cardiovascular devices.

Health CareMedical DeviceTherapeutics
Series DAug 14, 2023
Amount Raised: $13,634,767
Tagworks Pharmaceuticals

Nijmegen, Gelderland, The Netherlands

Tagworks Pharmaceuticals is a privately held biotech company

BiotechnologyHealth CareMedicalPharmaceutical
Series AJun 22, 2023
Amount Raised: $65,000,000